VNGLF - ETF AI Analysis
Top Page
Vanguard FTSE Developed Europe UCITS ETF Accum EUR (VNGLF)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has delivered strong year-to-date returns, showing solid momentum in developed European markets.
Leading European Blue-Chip Holdings
Top positions like ASML, HSBC, Novartis, Nestlé, Shell, Siemens, and Santander have generally shown strong or steady performance, helping support the fund’s results.
Low Expense Ratio
The fund’s very low fee means investors keep more of the returns compared with higher-cost ETFs.
Negative Factors
Underperforming Key Holdings
Some major positions, such as AstraZeneca and SAP, have shown weak performance, which can drag on the ETF’s overall returns.
Heavy Regional Focus on Europe
The ETF is strongly concentrated in European markets, with only limited U.S. exposure, so it may be more sensitive to economic and political issues in Europe.
Sector Tilt Toward Broad Market Exposure
A large share in the broad “General” sector and relatively small weights in areas like technology and communication services may limit participation in faster-growing industries.
VNGLF vs. SPDR S&P 500 ETF (SPY)
AUM3.05B
RegionEurope
Expense Ratio0.14%
Beta0.65
IssuerVanguard
Inception DateJul 23, 2019
Dividend YieldN/A
Asset ClassEquity
Index TrackedFTSE Developed Europe Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,419
30 Day Avg. Volume22,360
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
81.66Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering490
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VNGLF Summary
VNGLF is a Vanguard ETF that follows the FTSE Developed Europe Index, giving you broad exposure to many companies across major European countries like the UK, Germany, and France. It owns well-known names such as Nestlé and HSBC, and it automatically reinvests dividends, which can help your investment grow over time through compounding. Investors might consider this ETF to diversify beyond their home market and gain long-term growth from developed European economies. A key risk is that its value can rise or fall with European stock markets, so your investment can go up and down.
How much will it cost me?The Vanguard FTSE Developed Europe UCITS ETF (VNGLF) has an expense ratio of 0.1%, meaning you’ll pay $1 per year for every $1,000 invested. This is lower than average because the fund is passively managed, tracking the FTSE Developed Europe Index to keep costs down.
What would affect this ETF?Positive drivers for VNGLF include potential economic growth in developed European countries like Germany, France, and the UK, which could boost the performance of its top holdings in sectors such as financials, healthcare, and technology. However, negative factors such as rising interest rates or geopolitical tensions in Europe could impact market stability and weigh on the ETF's performance. Additionally, sector-specific challenges, like regulatory changes in healthcare or energy, could affect the fund's returns.
VNGLF Top 10 Holdings
This Vanguard Europe ETF leans heavily on a mix of continental heavyweights, with ASML acting as the star performer, its rising share price giving the fund a clear tech-powered tailwind. Financials like HSBC, Santander, and Allianz are also pulling their weight, adding steady, if sometimes choppy, support. On the defensive side, health-care names Roche and Novartis are quietly contributing, while AstraZeneca has been lagging and Nestlé looks more mixed, slightly dulling the overall shine. The fund is firmly rooted in developed Europe, offering broad, region-focused exposure.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.26% | $329.34M | €560.52B | 115.72% | 76 Outperform | |
| HSBC Holdings | 2.43% | $188.12M | £271.26B | 64.09% | 80 Outperform | |
| Roche Holding AG | 2.06% | $158.96M | $353.49B | 28.54% | 73 Outperform | |
| Novartis AG | 1.96% | $151.16M | CHF237.20B | 24.62% | 80 Outperform | |
| Nestlé SA | 1.72% | $133.24M | CHF201.43B | 1.06% | 71 Outperform | |
| Shell (UK) | 1.71% | $132.25M | £197.02B | 30.81% | 73 Outperform | |
| AstraZeneca | 1.70% | $131.79M | $253.04B | -0.69% | 80 Outperform | |
| Siemens | 1.60% | $123.36M | €207.83B | 19.06% | 74 Outperform | |
| Banco Santander | 1.37% | $106.08M | €193.07B | 55.81% | 73 Outperform | |
| Allianz | 1.27% | $97.85M | €170.64B | 28.18% | 67 Neutral |
VNGLF Technical Analysis
Positive
―
Price Trends
69.53
Positive
68.12
Positive
65.98
Positive
Market Momentum
0.20
Positive
52.29
Neutral
30.84
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VNGLF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.74, equal to the 50-day MA of 69.53, and equal to the 200-day MA of 65.98, indicating a neutral trend. The MACD of 0.20 indicates Positive momentum. The RSI at 52.29 is Neutral, neither overbought nor oversold. The STOCH value of 30.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VNGLF.
VNGLF Peer Comparison
Comparison Results
Performance Comparison
VNGLF
Vanguard FTSE Developed Europe UCITS ETF Accum EUR
70.53
12.02
20.54%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents